Terumo Cardiovascular Systems Corporation

Terumo Cardiovascular Systems Corporation, doing business as T C V S, a for-profit medical device manufacturer headquartered in Ann Arbor, Michigan, supplies specialized cardiovascular surgical equipment, implantable devices, blood parameter monitoring systems, and maintenance services to federal healthcare programs as a prime contractor across full-and-open procurements with no set-aside participation. The vendor operates exclusively as a prime (100% of awards) with no subcontract footprint and competes across 2,578 total awards, most recent in June 2026, across 31 distinct customer agencies with combined potential value of $58.4 million and obligated dollars of $28.2 million (48% of potential).

Terumo's capability portfolio centers on heart-lung bypass machines, stent graft systems, vascular grafts, surgical implants, blood gas analyzers, cardiac surgery monitors, and preventive maintenance and emergency repair services for proprietary cardiovascular equipment. Representative work includes a $213,300 June 2026 purchase order from Veterans Integrated Service Network 10 for a CDI OneView Processing Core blood parameter monitoring platform for cardiopulmonary bypass procedures at Cleveland VA Medical Center; a $434,936 June 2023 definitive contract from VISN 17 for preventive maintenance of Terumo Heart Perfusion Systems in Houston, Texas, running through June 2028; a $224,400 February 2024 purchase order from VISN 17 for preventive maintenance and repair services on heart-lung bypass units in San Antonio; and a $6.5 million Blanket Purchase Agreement with the Defense Health Agency for cardiovascular medical supplies for surgery, awarded August 2021 and extended through August 2023, representing the vendor's largest single vehicle. The VA market dominates customer concentration. Defense Health Agency leads by potential value (25 awards, $14 million), followed by Army Medical Command (109 awards, $12.1 million), and VISN 17 (118 awards, $3.7 million). The top five customers by potential value account for 59% of combined potential value. By award count, VISN 17 leads (118 awards, $3.7 million), Navy Bureau of Medicine and Surgery (128 awards, $1.3 million), and Army Medical Command (109 awards, $12.1 million) represent the three largest customer sets, with the top five capturing only 19% of total awards — indicating a deep long-tail of small orders across multiple VISN networks and military treatment facilities.

Terumo places task orders under five named Indefinite Delivery Vehicles, all VA-based: VA263P1042 (62 task orders, $1.2 million combined potential value), V580P7799 (35 task orders, $409 thousand), VA256P0215 (34 task orders, $383 thousand), V246P01213 (17 task orders, $77 thousand), and VA69DP0821 (6 task orders, $143 thousand). The vendor's work spans multiple NAICS codes, with Surgical and Medical Instrument Manufacturing (420 awards) and Surgical Appliance and Supplies Manufacturing (232 awards) as the primary categories, and Medical and Surgical Instruments, Equipment, and Supplies (PSC, 2,136 awards) dominating the service classification landscape. Recent activity shows a declining trend: 15 awards in 2024, 10 in 2025, and 5 in 2026 year-to-date. Nine awards totaling $1.3 million in combined potential value face ultimate completion within the next twenty-four months, representing near-term recompete exposure. All procurement actions carry sole-source justifications or no set-aside designation, reflecting the proprietary and specialized nature of Terumo's equipment and the vendor's position as original equipment manufacturer for most systems it services.